Neurotrophins (BDNF, NGF, Lion’s Mane)

Navigation

Upward Index: 02 - Compounds & Molecules MOC | Literature Dossier: Neurotrophins (BDNF, NGF, Lion’s Mane) - References

---

1. Pharmacodynamics & Mechanism of Action

Neurotrophins—principally Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF)—govern adult hippocampal neurogenesis (subgranular zone of the dentate gyrus), dendritic arborization, axonal myelination, and long-term synaptic consolidation. Because native BDNF ($27\text{ kDa}$ homodimer) and NGF cannot cross the blood-brain barrier (BBB), biohacking interventions utilize BBB-permeable small molecules that either stimulate endogenous astroglial neurotrophin transcription or act as direct TrkA/TrkB receptor agonists.

• Lion’s Mane (Hericium erinaceus — Hericenones & Erinacines):
  • Hericenones (A–H, from fruiting body) and NDPIH / Hericene A: Stimulate astroglial NGF and BDNF signaling cascades (ERK1/2 $\to$ CREB).
  • Erinacines (A–I, specifically Erinacine A from liquid-fermented mycelium): Low-molecular-weight cyathane diterpenoids ($\sim 432\text{ Da}$) that readily cross the BBB, potently upregulating hippocampal and locus coeruleus NGF and BDNF synthesis, promoting oligodendrocyte myelination, and reducing $\text{A}\beta$ plaque burden.
• Direct TrkB Agonists (7,8-DHF & 4’-DMA-7,8-DHF): 7,8-Dihydroxyflavone (7,8-DHF) binds the extracellular domain of the TrkB receptor with high affinity ($K_d\approx 320\text{ nM}$), provoking receptor dimerization and autophosphorylation at $\text{Tyr}515/\text{Tyr}816$ to activate downstream PI3K/Akt, MAPK/ERK, and PLC-$\gamma 1$ pathways—mimicking BDNF without activating pro-apoptotic ${\text{p75}}^{\text{NTR}}$ receptors. Its synthetic derivative 4’-DMA-7,8-DHF (Eutropoflavin) exhibits $\sim 3\text{–}5\times$ higher potency and prolonged duration.
• Bacopa monnieri (Bacosides A & B) & Polygala tenuifolia (Tenuigenin / Yuanzhi-1):
  • Bacopa monnieri: Upregulates hippocampal BDNF, enhances Tryptophan Hydroxylase (TPH2) and serotonin transporter (SERT) expression, increases dendritic branch points in the basolateral amygdala and hippocampus over 6–12 weeks, and upregulates endogenous SOD/catalase/glutathione peroxidase.
  • Polygala tenuifolia (BT-11): Triple monoamine reuptake inhibitor (DAT/NET/SERT), NMDA antagonist, and potent BDNF/TrkB inducer that prevents stress-induced hippocampal atrophy.

---

2. Pharmacokinetics & Extract Specifications

Compound	Active Constituents	Time to Structural Effect	Key Pharmacokinetic / Formulation Requirement
Lion’s Mane	Erinacine A (mycelium) + Hericenones / Hericene A (fruiting body)	$4\text{–}16\text{ weeks}$ (continuous; washes out within 4 weeks of stopping)	Dual-extract ($1:1$ hot-water fruiting body + alcohol-extracted liquid-fermented mycelium, NOT grain-spawn starch)
Bacopa monnieri	$45\%$ Bacosides (Synapsa / CDRI-08) or $24\%$ (Bacognize)	$8\text{–}12\text{ weeks}$ (no acute memory effect)	Fat-soluble triterpenoid saponins; requires lipid co-ingestion
7,8-DHF / 4’-DMA-7,8-DHF	Flavone TrkB agonist	Acute ($60\text{ min}$) + chronic synaptogenesis	Catechol ring undergoes rapid COMT methylation/glucuronidation; sublingual dosing increases bioavailability $3\times$
Polygala tenuifolia	$20:1$ root extract (Tenuifolin, DISS, 3,6’-disinapoylsucrose)	Acute mood ($45\text{ min}$) + 4-week neurogenesis	Sublingual $100\text{ mg}$ TID or oral $100\text{–}300\text{ mg}$

---

3. Dosing, Cycling & Synergies

• Standard Protocol:
  • Lion’s Mane Dual-Extract: $1,000\text{–}3,000\text{ mg/day}$ (standardized for $>25\%$ $\beta$-glucans + verified Erinacine A / Hericenones) in the morning.
  • Bacopa monnieri: $300\text{–}320\text{ mg/day}$ Synapsa (CDRI-08) (less serotonergic lethargy) or Bacognize (taken in the evening to leverage $5{\text{-HT}}_{1\text{A}/2\text{A}}$ sleep support) for at least 12 consecutive weeks.
  • 7,8-DHF: $15\text{–}30\text{ mg}$ sublingually (or 4’-DMA-7,8-DHF $8\text{ mg}$ early AM; cycle 5 days on / 2 days off to prevent TrkB receptor internalization/ubiquitination).
• Synergies: Paul Stamets / Neurogenesis Stack (Lion’s Mane + Niacin/flush B3 $50\text{–}100\text{ mg}$ for peripheral microvascular vasodilation), Zone 2 / HIIT aerobic exercise (releases myokine Irisin / FNDC5 and $\beta$-hydroxybutyrate / Lactate which deacetylate the BDNF promoter IV), and Omega-3 & Lipid Membrane Health.
• Contraindications & Biomarkers to Monitor:
  • Precautions: Lion’s Mane contains compounds that mildly inhibit 5$\alpha$-reductase and acts as a $\kappa$-opioid receptor (KOR) modulator (in Erinacine E); discontinue if libido reduction or dysphoria occurs. NGF elevation sensitizes peripheral TRPV1 and mast cell receptors—caution in histamine intolerance or chronic pruritus/neuropathic hyperalgesia. Bacopa inhibits acetylcholinesterase and can increase GI motility if taken fasted.
  • Biomarkers: Serum BDNF, DHT / Free Testosterone (if monitoring 5$\alpha$-reductase sensitivity), and validated delayed word-recall (RAVLT) scores.

---

4. Key Scientific Evidence Summary

• Lion’s Mane Human MCI Trial: Mori et al. (2009) demonstrated in a 16-week double-blind, placebo-controlled RCT ($N=30$) that $3,000\text{ mg/day}$ Hericium erinaceus significantly increased cognitive function scores at weeks 8, 12, and 16 ($p<0.001$), with scores declining 4 weeks after discontinuation.
• Discovery of 7,8-DHF as a TrkB Agonist: Jang et al. (2010) published in PNAS that 7,8-DHF binds TrkB with nanomolar affinity, crosses the BBB, induces TrkB phosphorylation in the rodent brain, and rescues neurogenesis and synaptic plasticity in BDNF-deficient models.
• Bacopa Memory Consolidation: Stough et al. (2001) and Kongkeaw et al. (2014, meta-analysis of 9 RCTs, $N=518$) confirmed that 12 weeks of Bacopa monnieri ($300\text{ mg/day}$) significantly improves speed of visual information processing, learning rate, and delayed memory consolidation ($p<0.01$).

See full study breakdowns in Neurotrophins (BDNF, NGF, Lion’s Mane) - References.